‘You have to have the goods’: Retiring Vir CEO George Scangos looks back on building great companies

He built companies across cancer, spinal muscular atrophy and an accelerate treatment for Covid-19 and, potentially, other major infectious diseases at three multibillion-dollar drug developers. Now he's handing Vir's reins to outgoing Bayer exec Marianne De Backer.

Previous Comfort Inn developer eyes project along I-65
Next With the market for eggs scrambled, Albuquerque restaurants face yet another challenge

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *